NEW YORK, June 7 – Bruker Daltonics will exclusively license MALDI-TOF mass spectrometry technology from Indiana University, and grant Applied Biosystems a sublicense to the technology, the companies said Thursday. 

The patented technology covers space-velocity correlation focusing (SVCF), or delayed extraction (DE), a technique related to MALDI-TOF mass spectrometry. SVCF technology improves the accuracy and sensitivity mass spectrometry analysis, according to the companies.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.